BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4185963)

  • 21. A small double-blind trial of an anovulant agent in acne vulgaris.
    Mackey JP
    Ir Med J; 1975 Apr; 68(8):203-4. PubMed ID: 124309
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of chlormadinone and mestranol on the formation of mammary tumours in Sprague-Dawley rats.
    Rieche K
    Rev Eur Etud Clin Biol; 1971 May; 16(5):458-62. PubMed ID: 4107067
    [No Abstract]   [Full Text] [Related]  

  • 23. [Physiological effects of estrogens on ovarian function. Personal study of the suppression of ovulation by "diphasic" therapy. Applications in pathology].
    Netter A; Pelissier C
    Presse Med (1893); 1966 Apr; 74(22):1129-30. PubMed ID: 4160054
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
    Krause W; Böhm W; Müller W
    Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical results and problems of oral contraceptives, a combination of norethindrone and mestranol (2)].
    Ueda Y; Hayashi K; Maruo M; Fujii O; Yagi T
    Saishin Igaku; 1965 Dec; 20(12):3234-53 passim. PubMed ID: 5869520
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical results of Lunarol, synthetic corpus luteum and follicle hormones preparation with special reference to corpus luteum insufficiency and amenorrhea].
    Iizuka R; Koi H; Saga M; Shibuya T; Hongo K
    Sanfujinka No Jissai; 1970; 19(3):322-30. PubMed ID: 4192774
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sequential treatment. Experimental and clinical study].
    Di Paola G; Mendizábal A; Usubiaga I; Ortega F
    Rev Argent Endocrinol Metab; 1966 Sep; 12(3):158-72. PubMed ID: 4170552
    [No Abstract]   [Full Text] [Related]  

  • 28. [Handling of the menopausal patient].
    Gonzalez Gutierrez JT
    Ginecol Obstet Mex; 1967 Oct; 22(132):1371-80. PubMed ID: 4186427
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serum enzyme examinations in the climacteric under the treatment with the estrogen-gestagen combination Ovosiston].
    Müller W; Bonow A; Klinger G; Hempel E
    Zentralbl Gynakol; 1969 Jul; 91(27):867-73. PubMed ID: 4188685
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hormonal therapy of acne vulgaris. Ovulation inhibitors in premenstrual acne].
    Schirren C; Immel L
    Munch Med Wochenschr; 1969 Aug; 111(35):1742-7. PubMed ID: 4185512
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of Ovosiston in prevention of bleeding after electroconization].
    Malachowski Z; Kaliński R
    Pol Tyg Lek; 1970 Jul; 25(30):1138-9. PubMed ID: 4194911
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of erythema nodosum with an estrogen-gestagen hormonal preparation].
    Spirov G; Vetsova N
    Vestn Dermatol Venerol; 1975 Feb; (2):57-8. PubMed ID: 50675
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of an oral contraceptive on adrenal and ovarian androgenic steroids.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1984 Jan; 63(1):12-4. PubMed ID: 6228751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

  • 35. ENDOMETRIAL EFFECTS OF MESTRANOL-NORETHINDRONE SEQUENTIAL THERAPY FOR ORAL CONTRACEPTION.
    BOARD JA; BORLAND DS
    Obstet Gynecol; 1964 Nov; 24():655-8. PubMed ID: 14227594
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of a new sequential contraceptive agent.
    Parkinson RW; McQuarrie HG; Ellsworth HS; Stone RA
    Obstet Gynecol; 1966 Aug; 28(2):239-46. PubMed ID: 4161460
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gestranol in treatment of excessive postpartum breast intumescence].
    Ostrzeński A
    Pol Tyg Lek; 1974 Mar; 29(12):489-90. PubMed ID: 4132234
    [No Abstract]   [Full Text] [Related]  

  • 38. [Valve of pharmacological hypophyseal inhibition in the treatment of cancer of the breast].
    Jayle MF; Chemama R; Ennuyer A; Bataini P
    Bull Cancer; 1966; 53(4):381-6. PubMed ID: 4166043
    [No Abstract]   [Full Text] [Related]  

  • 39. [Coronary infarction associated with ovulation inhibitors].
    Dejaco RM; Hartl O; Pürgyi P
    Wien Med Wochenschr; 1972 Nov; 122(43):630-2. PubMed ID: 4120546
    [No Abstract]   [Full Text] [Related]  

  • 40. Sequential mestranol and morethisterone in the treatment of the climacteric syndrome.
    Moore B
    Postgrad Med J; 1976; 52 Suppl 6():39-47. PubMed ID: 981118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.